Log in with your email address username.


[Correspondence] Primary chemotherapy versus primary surgery for ovarian cancer – Authors’ reply

We thank Maria Luisa Gasparri and Giuseppe Scaletta and colleagues for their comments on the CHORUS study.1 Both letters focus on median survival times that are lower than expected, possible explanations, and implications for interpretation of the trial result. This topic is very important, and we welcome this discussion.